|  Sign up!  

scientia

Return to Course Listing

 

 

CME: Successful Strategies for Addressing Patient Safety Hot Topics - Immunization and vaccine-preventable diseases as a patient and public safety concern

 


Program Description / Statement of Need:

In this online CME self-learning program: The overall learning activity will focus on Immunization and vaccine-preventable diseases as a patient and public safety concern, and the role of the physicians and allied health professions play in it. 

 

  • Immunization and vaccine-preventable diseases as a patient and public safety concern: In spite of record low levels of vaccine-preventable diseases over the last decade, there have been resurgences in pockets of communities, making it clear that they play an ongoing role in patient and public safety.  However, the Centers for Disease Control and Prevent (CDC) warns of the risk of complacency.  After considerable progress in the 1980s and early 90s, there has been a tapering of rates of adult vaccinations.  Notably influenza vaccination rates have plateaued since 1997, and just less than two thirds of geriatric patients have received the pneumococcal vaccine.  Of equal concern is a recent report that analyzed CDC data and showed that the rates of nonmedical exemptions from school immunization requirements have doubled in the last half-decade, possibly coinciding with the aforementioned outbreaks, which were characterized predominantly by pertussis, mumps, and varicella.  Reasons include religious and philosophical objections, although it is difficult to measure to what extent the controversy over thimerosal and the link between vaccines and autism – the result largely of a researcher whose work was discredited for misconduct and ethical breach – is recognized as unlikely by the CDC. The number of vaccine-preventable diseases in the U.S. has risen from five to 16 since the early 1960s.  It includes not only the aforementioned disease states but others ranging from the well-established such as hepatitis and polio to ones of newer focus and interest, such as human papillomavirus, which lowers the risk of not only infectious but also neoplastic disease.  That rates of vaccination have been halted or, in some cases, are falling speaks to a gap in practice, specifically communication to patients and the public at large that may itself be the result of a gap in education among healthcare professionals themselves.  Immunization schedules are regularly changed by the CDC, and that healthcare professionals are oftentimes unable to keep up with the steady publishing of literature and evolution of clinical practice, continuing education learning activities in this area are warranted.  And, as the CDC states: “for several reasons—including possible resurgence of disease, introduction of new vaccines, suboptimal immunization levels, cost-effectiveness, and gaps in sustainable immunization efforts—the need to focus on immunization rates remains crucial.”

Agenda

 

Introduction, Disclosures

Statistics

•          Immunization trends at a glance

•          Outbreaks

The challenge, key concepts, and solutions

•          Resurgence of disease

•          Risks associated with bioterrorism

•          Barriers to effective immunization

•          Introduction of new vaccines

•          Suboptimal immunization levels

•          Gaps in sustainable immunization efforts

•          Case studies in healthcare settings

Putting it all together: best practices, summary, and conclusions


 

Target Audience:

Healthcare professionals, including physicians, pharmacists, and mid-level practitioners working in acute care hospitals and other healthcare settings.



Program Objectives:

By the end of the session the participant will be able to:

    • Describe common barriers and challenges to effective immunization today
    • Formulate effective communication strategies to address patient concerns about vaccination.
    • Apply strategies to optimize vaccination rates in different healthcare setting scenarios.


    Accreditation:

    This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of ScientiaCME and The American Society of Medication Safety Officiers (ASMSO). ScientiaCME is accredited by the ACCME to provide continuing medical education for physicians.


     

    Credit Designation: ScientiaCME designates this educational activity for a maximum of 0.75 AMA PRA Category 1 Credit(s)™ toward the AMA Physician's Recognition Award. Physicians should only claim credit commensurate with the extent of their participation in the activity.

     

    This program is free of cost. Successful completion of the post-test and completion of the program evaluation is required to obtain a CME certificate.





    Release Date: June 30, 2014
    Expiration Date: June 30, 2016

    Faculty: Janet Dudley PharmD


    Faculty Disclosure and Resolution of COI:

     

    As an provider of continuing medical education, it is the policy of ScientiaCME to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, faculty and educational planners must disclose any significant relationships with commercial interests whose products or devices may be mentioned in faculty presentations, and any relationships with the commercial supporter of the activity. The intent of this disclosure is to provide the intended audience with information on which they can make their own judgments. Additionally, in the event a conflict of interest (COI) does exist, it is our policy to ensure that the COI is resolved in order to ensure the integrity of the CME activity. For this CME activity, any COI has been resolved thru content review by ScientiaCME.

    Faculty Disclosure: Janet Dudley, PharmD reports that he has no relevant financial disclosures.

    Disclosures of Educational Planner: Charles Turck, PharmD has no relevant financial disclosures.

     

    Disclosures of Educational Planner: Ambra King, PharmD (ASMSO) has no financial disclosures.

     

    Commercial Support Disclosure: This program is supported by educational grants from Boehringer Ingelheim.

     

    Viewing Requirements:

     

    PC Windows 2000 or above
    Internet Explorer 5.5
    Adobe Acrobat Reader*

    MAC
    Mac OS 10.2.8
    Safari
    Adobe Acrobat Reader*
    Internet Explorer is not supported on the Macintosh

     

    *Required to view Printable PDF Version

     

    Privacy Policy

     

    Instructions:


    -Read the learning objectives and faculty disclosures above

    -Take the Pre-Test (optional). Completion of the pre-test will help us evaluate the knowedge gained by participating in this CME activity.

    -View the on-line program. You may view this is in more than one session, and may pause or repeat any portion of the presentation if you need to.

    -Take the post-test

    -Complete the program evaluation and CME registration. A CE certificate will be emailed to you.



    Perform Pre-Test (optional)
    Please take a few minutes to participate in the optional pre-test. It will help us measure the knowledge gained by participating in this activity.


    Download the Presentation (optional)


     

    View the online program

     

    Perform Post-Test


    Complete the Symposium Evaluation and Request CE Certificate



Commercial Support Disclosure: This program is supported by educational grants from Boehringer Ingelheim.

 


Your feedback is important to us. Please Contact Us to let us know how to make this site better. Thank you.